日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

HIV integration and the establishment of latency in CCL19-treated resting CD4(+) T cells require activation of NF-κB

HIV 整合和 CCL19 处理的静息 CD4(+) T 细胞中的潜伏期建立需要激活 NF-κB

Suha Saleh, Hao K Lu, Vanessa Evans, David Harisson, Jingling Zhou, Anthony Jaworowski, Georgina Sallmann, Karey Y Cheong, Talia M Mota, Surekha Tennakoon, Thomas A Angelovich, Jenny Anderson, Andrew Harman, Anthony Cunningham, Lachlan Gray, Melissa Churchill, Johnson Mak, Heidi Drummer, Dimitrios N

Entinostat is a histone deacetylase inhibitor selective for class 1 histone deacetylases and activates HIV production from latently infected primary T cells

Entinostat 是一种组蛋白去乙酰化酶抑制剂,对 1 类组蛋白去乙酰化酶具有选择性,可激活潜伏感染的原代 T 细胞产生 HIV

Fiona Wightman, Hao K Lu, Ajantha E Solomon, Suha Saleh, Andrew N Harman, Anthony L Cunningham, Lachlan Gray, Melissa Churchill, Paul U Cameron, Anthony E Dear, Sharon R Lewin

Constrained use of CCR5 on CD4+ lymphocytes by R5X4 HIV-1: efficiency of Env-CCR5 interactions and low CCR5 expression determine a range of restricted CCR5-mediated entry

R5X4 HIV-1 限制 CCR5 在 CD4+ 淋巴细胞上的使用:Env-CCR5 相互作用的效率和低 CCR5 表达决定了一系列受限制的 CCR5 介导的进入

Lamorris M Loftin, Martha F Kienzle, Yanjie Yi, Benhur Lee, Fang-Hua Lee, Lachlan Gray, Paul R Gorry, Ronald G Collman